Jazz Pharmaceuticals EBITDA 2010-2024 | JAZZ
- Jazz Pharmaceuticals 2023 EBITDA was 1.217B, a 115.85% increase from 2022.
- Jazz Pharmaceuticals 2022 EBITDA was 0.564B, a 21.97% decline from 2021.
- Jazz Pharmaceuticals 2021 EBITDA was 0.723B, a 10.12% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.